{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:07:13Z","timestamp":1789744033861,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41372-026-02568-2","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:03:56Z","timestamp":1770109436000},"page":"1678-1684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and safety of diazoxide in the neonatal intensive care unit"],"prefix":"10.1038","volume":"46","author":[{"given":"Lucas C.","family":"Collins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-2872","authenticated-orcid":false,"given":"Katherine B.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeral N.","family":"Tolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyaria D.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4156-8543","authenticated-orcid":false,"given":"Rachel G.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2568_CR1","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJM196508122730707","volume":"273","author":"M Cornblath","year":"1965","unstructured":"Cornblath M, Reisner SH. Blood glucose in the neonate and its clinical significance. N Engl J Med. 1965;273:378\u201381.","journal-title":"N Engl J Med"},{"key":"2568_CR2","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jpeds.2015.02.045","volume":"166","author":"CA Stanley","year":"2015","unstructured":"Stanley CA, Rozance PJ, Thornton PS, De Leon DD, Harris D, Haymond MW, et al. Re-evaluating \u201ctransitional neonatal hypoglycemia\u201d: mechanism and implications for management. J Pediatr. 2015;166:1520\u20135 e1.","journal-title":"J Pediatr"},{"key":"2568_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1179102","volume":"14","author":"M Roeper","year":"2023","unstructured":"Roeper M, Hoermann H, Kummer S, Meissner T. Neonatal hypoglycemia: lack of evidence for a safe management. Front Endocrinol (Lausanne). 2023;14:1179102.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2568_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0022-3476(81)80583-5","volume":"98","author":"JM Saudubray","year":"1981","unstructured":"Saudubray JM, Marsac C, Limal JM, Dumurgier E, Charpentier C, Ogier H, et al. Variation in plasma ketone bodies during a 24-hour fast in normal and in hypoglycemic children: relationship to age. J Pediatr. 1981;98:904\u20138.","journal-title":"J Pediatr"},{"key":"2568_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.pcl.2015.04.010","volume":"62","author":"M Guemes","year":"2015","unstructured":"Guemes M, Hussain K. Hyperinsulinemic Hypoglycemia. Pediatr Clin North Am. 2015;62:1017\u201336.","journal-title":"Pediatr Clin North Am"},{"key":"2568_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jpeds.2015.03.057","volume":"167","author":"PS Thornton","year":"2015","unstructured":"Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. J Pediatr. 2015;167:238\u201345.","journal-title":"J Pediatr"},{"key":"2568_CR7","first-page":"575","volume":"127","author":"F Committee on","year":"2011","unstructured":"Committee on F, Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127:575\u20139.","journal-title":"Pediatrics"},{"key":"2568_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1542\/pir.2016-0063","volume":"38","author":"A Thompson-Branch","year":"2017","unstructured":"Thompson-Branch A, Havranek T. Neonatal Hypoglycemia. Pediatr Rev. 2017;38:147\u201357.","journal-title":"Pediatr Rev"},{"key":"2568_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpeds.2005.10.002","volume":"148","author":"FM Hoe","year":"2006","unstructured":"Hoe FM, Thornton PS, Wanner LA, Steinkrauss L, Simmons RA, Stanley CA. Clinical features and insulin regulation in infants with a syndrome of prolonged neonatal hyperinsulinism. J Pediatr. 2006;148:207\u201312.","journal-title":"J Pediatr"},{"key":"2568_CR10","unstructured":"Med D Label: PROGLYCEM- diazoxide suspension 2023 [Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2."},{"key":"2568_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000531766","volume":"97","author":"DD De Leon","year":"2024","unstructured":"De Leon DD, Arnoux JB, Banerjee I, Bergada I, Bhatti T, Conwell LS, et al. International Guidelines for the Diagnosis and Management of Hyperinsulinism. Horm Res Paediatr. 2024;97:279\u201398.","journal-title":"Horm Res Paediatr"},{"key":"2568_CR12","first-page":"199","volume":"18","author":"CB Sweet","year":"2013","unstructured":"Sweet CB, Grayson S, Polak M. Management strategies for neonatal hypoglycemia. J Pediatr Pharmacol Ther. 2013;18:199\u2013208.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2568_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1515\/jpem-2012-0224","volume":"25","author":"S Hu","year":"2012","unstructured":"Hu S, Xu Z, Yan J, Liu M, Sun B, Li W, et al. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism. J Pediatr Endocrinol Metab. 2012;25:1119\u201322.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2568_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4274\/jcrpe.1891","volume":"7","author":"K Rozenkova","year":"2015","unstructured":"Rozenkova K, Guemes M, Shah P, Hussain K. The Diagnosis and Management of Hyperinsulinaemic Hypoglycaemia. J Clin Res Pediatr Endocrinol. 2015;7:86\u201397.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"2568_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0367-x","volume":"10","author":"A Welters","year":"2015","unstructured":"Welters A, Lerch C, Kummer S, Marquard J, Salgin B, Mayatepek E, et al. Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers. Orphanet J Rare Dis. 2015;10:150.","journal-title":"Orphanet J Rare Dis"},{"key":"2568_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41372-018-0218-4","volume":"38","author":"KD Gray","year":"2018","unstructured":"Gray KD, Dudash K, Escobar C, Freel C, Harrison T, McMillan C, et al. Prevalence and safety of diazoxide in the neonatal intensive care unit. J Perinatol. 2018;38:1496\u2013502.","journal-title":"J Perinatol"},{"key":"2568_CR17","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/apa.14252","volume":"107","author":"B Balachandran","year":"2018","unstructured":"Balachandran B, Mukhopadhyay K, Sachdeva N, Walia R, Attri SV. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects. Acta Paediatr. 2018;107:990\u20135.","journal-title":"Acta Paediatr"},{"key":"2568_CR18","doi-asserted-by":"publisher","first-page":"e059452","DOI":"10.1136\/bmjopen-2021-059452","volume":"12","author":"D Laing","year":"2022","unstructured":"Laing D, Walsh E, Alsweiler JM, Hanning SM, Meyer MP, Ardern J, et al. Oral diazoxide versus placebo for severe or recurrent neonatal hypoglycaemia: Neonatal Glucose Care Optimisation (NeoGluCO) study - a randomised controlled trial. BMJ Open. 2022;12:e059452.","journal-title":"BMJ Open"},{"key":"2568_CR19","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/adc.64.10.1496","volume":"64","author":"YK Abu-Osba","year":"1989","unstructured":"Abu-Osba YK, Manasra KB, Mathew PM. Complications of diazoxide treatment in persistent neonatal hyperinsulinism. Arch Dis Child. 1989;64:1496\u2013500.","journal-title":"Arch Dis Child"},{"key":"2568_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1515\/JPEM.2007.20.8.939","volume":"20","author":"TD Nebesio","year":"2007","unstructured":"Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA. Development of pulmonary hypertension in an infant treated with diazoxide. J Pediatr Endocrinol Metab. 2007;20:939\u201344.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2568_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1515\/jpem.2011.238","volume":"24","author":"F Demirel","year":"2011","unstructured":"Demirel F, Unal S, Cetin II, Esen I, Arasli A. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide. J Pediatr Endocrinol Metab. 2011;24:603\u20135.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2568_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/MED.0000000000000027","volume":"21","author":"PJ Rozance","year":"2014","unstructured":"Rozance PJ. Update on neonatal hypoglycemia. Curr Opin Endocrinol Diabetes Obes. 2014;21:45\u201350.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2568_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1136\/adc.60.5.500-b","volume":"60","author":"DR Gillies","year":"1985","unstructured":"Gillies DR. Complications of diazoxide in the treatment of nesidioblastosis. Arch Dis Child. 1985;60:500\u20131.","journal-title":"Arch Dis Child"},{"key":"2568_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000497458","volume":"91","author":"P Thornton","year":"2019","unstructured":"Thornton P, Truong L, Reynolds C, Hamby T, Nedrelow J. Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism. Horm Res Paediatr. 2019;91:25\u201332.","journal-title":"Horm Res Paediatr"},{"key":"2568_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clp.2010.01.016","volume":"37","author":"AR Spitzer","year":"2010","unstructured":"Spitzer AR, Ellsbury DL, Handler D, Clark RH. The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system\u2013tools for \u201cmeaningful use\u201d in continuous quality improvement. Clin Perinatol. 2010;37:49\u201370.","journal-title":"Clin Perinatol"},{"key":"2568_CR26","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","journal-title":"JAMA"},{"key":"2568_CR27","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1542\/peds.2009-0913","volume":"125","author":"IE Olsen","year":"2010","unstructured":"Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on United States data. Pediatrics. 2010;125:e214\u201324.","journal-title":"Pediatrics"},{"key":"2568_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/sim.4780040112","volume":"4","author":"J Cuzick","year":"1985","unstructured":"Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985;4:87\u201390.","journal-title":"Stat Med"},{"key":"2568_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41372-020-0589-1","volume":"40","author":"KR Uquillas","year":"2020","unstructured":"Uquillas KR, Lee RH, Sardesai S, Chen E, Ihenacho U, Cortessis VK, et al. Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. J Perinatol. 2020;40:1339\u201348.","journal-title":"J Perinatol"},{"key":"2568_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/14767058.2017.1391781","volume":"32","author":"R Bromiker","year":"2019","unstructured":"Bromiker R, Perry A, Kasirer Y, Einav S, Klinger G, Levy-Khademi F. Early neonatal hypoglycemia: incidence of and risk factors. A cohort study using universal point of care screening. J Matern Fetal Neonatal Med. 2019;32:786\u201392.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2568_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jpeds.2012.05.022","volume":"161","author":"DL Harris","year":"2012","unstructured":"Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161:787\u201391.","journal-title":"J Pediatr"},{"key":"2568_CR32","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1080\/14767058.2019.1568985","volume":"33","author":"J Stark","year":"2020","unstructured":"Stark J, Simma B, Blassnig-Ezeh A. Incidence of hypoglycemia in newborn infants identified as at risk. J Matern Fetal Neonatal Med. 2020;33:3091\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2568_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamapediatrics.2023.3957","volume":"177","author":"M O\u2019Brien","year":"2023","unstructured":"O\u2019Brien M, Gilchrist C, Sadler L, Hegarty JE, Alsweiler JM. Infants Eligible for Neonatal Hypoglycemia Screening: A Systematic Review. JAMA Pediatr. 2023;177:1187\u201396.","journal-title":"JAMA Pediatr"},{"key":"2568_CR34","doi-asserted-by":"crossref","unstructured":"Stewart DL, Barfield WD, Committee On F, Newborn. Updates on an At-Risk Population: Late-Preterm and Early-Term Infants. Pediatrics. 2019;144:e20192760.","DOI":"10.1542\/peds.2019-2760"},{"key":"2568_CR35","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jama.2021.7217","volume":"326","author":"NS Shah","year":"2021","unstructured":"Shah NS, Wang MC, Freaney PM, Perak AM, Carnethon MR, Kandula NR, et al. Trends in Gestational Diabetes at First Live Birth by Race and Ethnicity in the US, 2011-2019. JAMA. 2021;326:660\u20139.","journal-title":"JAMA"},{"key":"2568_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00431-019-03544-z","volume":"179","author":"AS Davidov","year":"2020","unstructured":"Davidov AS, Elkon-Tamir E, Haham A, Shefer G, Weintrob N, Oren A, et al. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment. Eur J Pediatr. 2020;179:597\u2013602.","journal-title":"Eur J Pediatr"},{"key":"2568_CR37","doi-asserted-by":"crossref","unstructured":"Keyes ML, Healy H, Sparger KA, Orth LE, Geha M, Roumiantsev S, et al. Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide. Pediatrics. 2021;147:e20193202.","DOI":"10.1542\/peds.2019-3202"},{"key":"2568_CR38","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41372-020-00891-w","volume":"41","author":"MJ Bailey","year":"2021","unstructured":"Bailey MJ, Rout A, Harding JE, Alsweiler JM, Cutfield WS, McKinlay CJD. Prolonged transitional neonatal hypoglycaemia: characterisation of a clinical syndrome. J Perinatol. 2021;41:1149\u201357.","journal-title":"J Perinatol"},{"key":"2568_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1530\/EJE-09-0861","volume":"162","author":"SE Flanagan","year":"2010","unstructured":"Flanagan SE, Kapoor RR, Mali G, Cody D, Murphy N, Schwahn B, et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol. 2010;162:987\u201392.","journal-title":"Eur J Endocrinol"},{"key":"2568_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cen.14987","volume":"100","author":"N Malhotra","year":"2024","unstructured":"Malhotra N, Yau D, Cunjamalay A, Gunasekara BSA, Gilbert C, et al. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism. Clin Endocrinol (Oxf). 2024;100:132\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2568_CR41","doi-asserted-by":"publisher","first-page":"e2415764","DOI":"10.1001\/jamanetworkopen.2024.15764","volume":"7","author":"D Laing","year":"2024","unstructured":"Laing D, Walsh EPG, Alsweiler JM, Hanning SM, Meyer MP, Ardern J, et al. Diazoxide for Severe or Recurrent Neonatal Hypoglycemia: A Randomized Clinical Trial. JAMA Netw Open. 2024;7:e2415764.","journal-title":"JAMA Netw Open"},{"key":"2568_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/bmj.2.5298.159","volume":"2","author":"DE Hutcheon","year":"1962","unstructured":"Hutcheon DE, Barthalmus KS. Antihypertensive action of diazoxide. A new benzothiazine with antidiuretic properties. Br Med J. 1962;2:159\u201361.","journal-title":"Br Med J"},{"key":"2568_CR43","doi-asserted-by":"publisher","first-page":"e0246463","DOI":"10.1371\/journal.pone.0246463","volume":"16","author":"X Chen","year":"2021","unstructured":"Chen X, Feng L, Yao H, Yang L, Qin Y. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis. PLoS One. 2021;16:e0246463.","journal-title":"PLoS One"},{"key":"2568_CR44","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1210\/jc.2018-01613","volume":"103","author":"A Herrera","year":"2018","unstructured":"Herrera A, Vajravelu ME, Givler S, Mitteer L, Avitabile CM, Lord K, et al. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide. J Clin Endocrinol Metab. 2018;103:4365\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"2568_CR45","doi-asserted-by":"publisher","first-page":"e1435","DOI":"10.1055\/s-0043-1764385","volume":"41","author":"M Duggal","year":"2024","unstructured":"Duggal M, Moore SS, Simoneau J, Girard G, Gernet IB, Oettingen JEV, et al. Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide. Am J Perinatol. 2024;41:e1435\u2013e44.","journal-title":"Am J Perinatol"},{"key":"2568_CR46","doi-asserted-by":"crossref","unstructured":"Brar PC, Heksch R, Cossen K, De Leon DD, Kamboj MK, Marks SD, et al. Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism. J Clin Endocrinol Metab. 2020;105:dgaa543.","DOI":"10.1210\/clinem\/dgaa543"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02568-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:22:59Z","timestamp":1789741379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02568-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02568-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RGG has received support from industry for research services (\n                      \n                      ).","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}